Seattle-based University of Washington Medicine and Next Steps Chicago were among the first commercial U.S. sales. Arc-EX earned de novo classification in December and is the first FDA-approved technology that is indicated to improve hand strength in people with spinal cord injuries.
Onward Medical is seeking a CE mark from the European Union for Arc-EX in 2025 along with a commercial launch abroad.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
